Sanguinarine analogs as PP2C inhibitors are disclosed for the treatment of various cancers, as well as methods of synthesizing such analogs.Linvention concerne des analogues de sanguinarine utilisés en tant quinhibiteurs de PP2C pour le traitement de divers cancers, ainsi que des méthodes de synthèse desdits analogues.